- Home
- BRNS vs APYX Comparison
BRNS vs APYX Comparison
Compare BRNS & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRNS
- APYX
- Stock Information
- Founded
- BRNS 2016
- APYX 1982
- Country
- BRNS United Kingdom
- APYX United States
- Employees
- BRNS N/A
- APYX N/A
- Industry
- BRNS Biotechnology: Pharmaceutical Preparations
- APYX Medical/Dental Instruments
- Sector
- BRNS Health Care
- APYX Health Care
- Exchange
- BRNS Nasdaq
- APYX Nasdaq
- Market Cap
- BRNS 36.0M
- APYX 84.7M
- IPO Year
- BRNS 2021
- APYX 1987
- Fundamental
- Price
- BRNS $1.02
- APYX $2.05
- Analyst Decision
- BRNS Strong Buy
- APYX Hold
- Analyst Count
- BRNS 1
- APYX 2
- Target Price
- BRNS $3.00
- APYX N/A
- AVG Volume (30 Days)
- BRNS 18.3K
- APYX 107.6K
- Earning Date
- BRNS 08-07-2025
- APYX 08-07-2025
- Dividend Yield
- BRNS N/A
- APYX N/A
- EPS Growth
- BRNS N/A
- APYX N/A
- EPS
- BRNS N/A
- APYX N/A
- Revenue
- BRNS $14,969,000.00
- APYX $47,288,000.00
- Revenue This Year
- BRNS N/A
- APYX $2.25
- Revenue Next Year
- BRNS N/A
- APYX $6.76
- P/E Ratio
- BRNS N/A
- APYX N/A
- Revenue Growth
- BRNS 4381.74
- APYX N/A
- 52 Week Low
- BRNS $0.64
- APYX $0.76
- 52 Week High
- BRNS $1.58
- APYX $2.73
- Technical
- Relative Strength Index (RSI)
- BRNS 55.28
- APYX 51.13
- Support Level
- BRNS $0.96
- APYX $1.70
- Resistance Level
- BRNS $1.04
- APYX $2.73
- Average True Range (ATR)
- BRNS 0.06
- APYX 0.26
- MACD
- BRNS 0.01
- APYX -0.05
- Stochastic Oscillator
- BRNS 52.15
- APYX 33.98
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.
About APYX Apyx Medical Corporation
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.